"suggests between $6.61 and $7.99 is fair and reasonable" ..... Cosette offered $ 7.40 and there are some thoughts of it being worth between $ 10-15 in 12 months.
The article reads as if MYX needs to accept an offer... any offer ... as long as it sits above $ 6.61.
One of the other articles I was referrring two was listed in the HC daily bulletins .. can't recall the specifics ... but in short it was stating 2 weeks ago that the deal was dead in the water and shareholders need not worry about voting on the proposal ...... as this one does.
Can't recall where I read the third aricle.
The statenent that "DataRoom understands Mayne has been prepared to go to the negotiating table with Cosette in a quest to see if it can get a deal done, albeit at a lower price" contradicts MYX's public statements.
Of course all articles are opinions only, but in my view the article has a negative bias. (Obviously just my reading and opinion on the opinion expressed in the article)
- Forums
- ASX - By Stock
- MYX
- Ann: Becoming a substantial holder
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

Ann: Becoming a substantial holder, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
1 | 905 | 5.060 |
1 | 1000 | 5.050 |
3 | 4055 | 5.040 |
1 | 600 | 5.030 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.170 | 905 | 1 |
5.180 | 2396 | 2 |
5.190 | 5905 | 2 |
5.200 | 157 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online